NITTOBO MEDICAL Co.,Ltd

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40009334

Informations générales

Localisation

Japan

Asia

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

17/10/2024

Objectifs à court terme (Near-Term)

Engagement de réduction des émissions à horizon FY2030

Statut

Targets set

Classification

1.5°C

Année cible

FY2030

Progression vers l'objectif0%

2015 (année de référence)FY2030

Description complète des objectifs

Nittobo Medical Co.,Ltd commits to reduce absolute scope 1 and 2 GHG emissions 42% by FY2030 from FY2022 base year. Nittobo Medical Co.,Ltd also commits to reduce absolute scope 3 GHG emissions 25% within the same timeframe.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Source : Science Based Targets initiative | Données publiques